FDA Approves Merilog, Biosimilar Product of Insulin Aspart (Novolog) for Diabetes

Retrieved on: 2025-02-14 20:50:19

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves Merilog, Biosimilar Product of Insulin Aspart (Novolog) for Diabetes. View article details on hiswai:

Excerpt

Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved by the FDA, enhancing treatment accessibility for diabetes patients.

Article found on: www.hcplive.com